Ultragenyx Pharmaceutical Inc.【RARE】 営業キャッシュフローの推移

機能の使い方
(単位:千ドル) 営業キャッシュフロー 前年比(%)
4Q25 -99,829 +25.6%
3Q25 -91,423 +36.5%
2Q25 -108,273 +40.7%
1Q25 -166,475 -12.7%
4Q24 -79,503 -5.2%
3Q24 -66,995 -43.2%
2Q24 -76,963 -33.7%
1Q24 -190,727 +21.6%
4Q23 -83,904 -7.1%
3Q23 -117,874 +23.6%
2Q23 -116,161 +50.4%
1Q23 -156,867 +33.5%
4Q22 -90,342 +66.2%
3Q22 -95,345 +59.8%
2Q22 -77,257 +18.2%
1Q22 -117,521 -26.2%
4Q21 -54,344 -13.0%
3Q21 -59,649 -3.7%
2Q21 -65,356 -174.8%
1Q21 -159,346 +67.5%
4Q20 -62,452 -13.3%
3Q20 -61,967 -30.0%
2Q20 87,351 -198.1%
1Q20 -95,152 -0.7%
4Q19 -72,039 +29.0%
3Q19 -88,506 +28.0%
2Q19 -89,063 -
1Q19 -95,775 +7.0%
4Q18 -55,853 -31.7%
3Q18 -69,157 +11.6%
1Q18 -89,478 +46.2%
4Q17 -81,823 +71.6%
3Q17 -61,993 +115.7%
2Q17 -48,822 +23.1%
1Q17 -61,205 +36.3%
4Q16 -47,680 +17.9%
3Q16 -28,745 -6.1%
2Q16 -39,655 +129.6%
1Q16 -44,895 +154.2%
4Q15 -40,444 -
3Q15 -30,601 +177.4%
2Q15 -17,273 +64.1%
1Q15 -17,659 +111.8%
3Q14 -11,030 -
2Q14 -10,529 -
1Q14 -8,336 -